Setting the Scene: A Pharmaceutical Power Play Imagine a pharmaceutical giant thrusting $50 billion into U.S. soil to significantly reshape the medical landscape. This is precisely the scenario as AstraZeneca embarks on a strategic mission to bolster its manufacturing facilities across the country.
Recent developments in the field of gene therapy have placed a spotlight on Sarepta Therapeutics, a leading entity in the Duchenne muscular dystrophy (DMD) treatment sphere. The sudden FDA intervention regarding the safety of Sarepta's Elevidys therapy has prompted a comprehensive market analysis
The pharmaceutical industry is witnessing a significant shift in focus toward weight-loss drugs, which are capturing an increasing share of healthcare spending. This is driven by new treatments, such as Wegovy by Novo Nordisk and Zepbound by Eli Lilly, which have gained popularity for their
Within the evolving landscape of the workforce, a distinct generational divide is emerging in sick leave patterns, with Baby Boomers reportedly taking more sick days than their younger counterparts, like Gen X, Millennials, and Gen Z. In 2025, the average sick days for Boomers stood at 4.0, while
Ever wondered about the unseen challenges faced by employees working abroad? According to Towergate Employee Benefits, only 36% of companies adequately tailor their health support for employees in different countries. Consider the stress, isolation, and unexpected medical expenses that can arise
Pre-employment medical screenings are a common practice, intended to ensure candidates are suitable for the physical and mental demands of specific roles. However, when these inquiries become excessively intrusive or irrelevant, they can cross boundaries and violate privacy rights and employment
